Recent research offers previously unavailable opportunities to make substantial progress in GC therapy. Targeted therapies have revolutionized GC gastric cancer new treatment, but benefit remain limited, with only a few months increase in overall survival.
The current challenge is the proper stratification of patients, in order to implement an adequate therapy, and to identify primary and acquired resistance to treatment. As such, this project focuses on the valorification of metastatic cancer and bone research infrastructure of the partners. Results could have a major importance in the field of gastric cancer therapies, contributing to an improved quality of life and overall survival of GC patients, by translating scientific results in new opportunities of personalized treatment.
Main objective THERRES is an extremely ambitious and innovative project, focusing on the association of immunotherapy gastric cancer new treatment molecular oriented drugs in gastric cancer, as a modern method of treatment.
The project aims gastric cancer new treatment implement a new classification system to distinguish between gastric cancer subtypes and to characterize regulatory molecules of immune function immune checkpoints Specific objectives: Objective 1: Identification of biomarkers and potential therapy targets in GC subtypes defined on the basis of recent genomic classifications Objective 2: Identifying response and resistance biomarkers to standard anti-HER2, anti-MET and anti-VEGF therapy in GC Objective 3: Characterizing vascular stroma particularities in GC, including the role on immune checkpoints in GC subtypes.
As a key result, the project will generate instruments to guide treatment decisions and help in gastric cancer new treatment management of GC patients through a personalized approach. The result of the present project will contribute to improving the performance, quality and international visibility of Romanian scientific results in the oncology field.
Institutul nostru are o veche traditie in patologia dificila cardio-vasculara, gastric cancer new treatment, renala, digestiva, hematologica, etc.
La inceput de mileniu III specialistii gastric cancer new treatment Institutul Clinic Fundeni sunt pregatiti sa abordeze asemenea probleme nu numai prin prisma practicii de zi cu zi, ci gastric cancer new treatment sub aspectul cercetarii fundamentale.